Non-pharmacological treatment of refractory angina: The coronary sinus reducer, the new kid on the block

Rev Port Cardiol (Engl Ed). 2021 May;40(5):371-382. doi: 10.1016/j.repce.2020.09.003. Epub 2021 Apr 6.

Abstract

Refractory angina is defined as persistent angina (≥3 months) despite optimal medical and interventional therapies. It is increasing in frequency, due to the success of current medical and interventional therapies in improving the prognosis of coronary artery disease. Long-term mortality is similar to that of patients with asymptomatic stable disease, but it affects patients' quality of life, and has a significant impact on health care resources. Several therapeutic targets have been investigated, most with disappointing results. Many of the techniques have been abandoned because of lack of efficacy, safety issues, or economic and logistic limitations to wider applicability. The primary focus of this review is the coronary sinus Reducer, supporting evidence for which, although scarce, is promising regarding safety and efficacy in improving anginal symptoms and quality of life. It is also accessible to virtually all interventional cardiology departments.

Keywords: Angina refratária; Coronary artery disease; Coronary sinus Reducer device; Dispositivo de redução do seio coronário – Reducer; Doença coronária; Non-pharmacological antianginal therapy; Refractory angina; Terapia antianginosa não farmacológica.

Publication types

  • Review

MeSH terms

  • Angina Pectoris / therapy
  • Coronary Artery Disease* / therapy
  • Coronary Sinus*
  • Humans
  • Quality of Life
  • Treatment Outcome